Device Trial Radar · NCT07742787
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study
Last checked: Nov 20, 2026Latest source record: Aug 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
20
Actual
Start
Jul 4, 2024
Primary completion
Sep 6, 2026
Study completion Mar 7, 2027
Sponsor
- Lead sponsor
- Hippocration General HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- ReCor Medical, Inc.
- First posted
- Aug 3, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RDN-CKD GR Study is a prospective, randomized (1:1), double-blind (unblinded interventionalist and blinded study team), sham controlled study. The purpose of the RDN-CKD GR Study is to demonstrate that renal denervation (RDN) effectively reduces 24-h ambulatory BP in 20 patients with chronic kidney disease (CKD) stage 3a or 3b.
Conditions
- Uncontrolled Hypertension
- Renal Denervation
- Chronic Kidney Disease (Stage 3)
Interventions
Renal denervationDevice
The Paradise® Renal Denervation System (Paradise System) is CE-marked in countries accepting the CE mark. The system is a catheter-based device designed to use ultrasound energy to thermally ablate the afferent and efferent nerves surrounding the renal artery and serving the kidney.
Sham procedure controlDiagnostic test
sham procedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- change in systolic 24-h ambulatory BPTime frame: at 6 month post-procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hippocratio General Hospital
Athens, Greece
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.